Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Other Non-Current Liabilities came in at $435.0 million in Q2 2026, up 353.12% YoY from $96.0 million in Q2 2025, and down 5.02% on a QoQ basis from $458.0 million in Q1 2026.
Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Other Non-Current Liabilities data on file, last reported at $435.0 million in Q2 2026.
- Quarterly Other Non-Current Liabilities rose 353.12% year-over-year to $435.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $435.0 million (up 353.12% YoY) and the FY2025 annual result came in at $521.0 million, up 21.16% from the prior year.
- Other Non-Current Liabilities slipped to $435.0 million in Q2 2026, from $458.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $521.0 million in Q4 2025 to a low of $4.0 million in Q2 2022.
- A 5-year average of $194.1 million and a median of $71.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities changed 0.0% — and 2025, when it jumped 986.96%.
- Tracing BLCO's Other Non-Current Liabilities over 5 years: stood at $329.0 million in 2022, then climbed by 20.67% to $397.0 million in 2023, then advanced by 8.31% to $430.0 million in 2024, then rose by 21.16% to $521.0 million in 2025, then dropped by 16.51% to $435.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $435.0 million (Q2 2026), $458.0 million (Q1 2026), and $521.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 435.00 Mn |
| Mar 31, 2026 | 458.00 Mn |
| Dec 31, 2025 | 521.00 Mn |
| Sep 30, 2025 | 500.00 Mn |
| Jun 30, 2025 | 96.00 Mn |
| Mar 31, 2025 | 114.00 Mn |
| Dec 31, 2024 | 430.00 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 44.00 Mn |
| Mar 31, 2024 | 45.00 Mn |
| Dec 31, 2023 | 397.00 Mn |
| Sep 30, 2023 | 42.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 298.00 Mn |